ÂÜÀòÂÒÂ×

Kazi Yasin Helal, PhD, is a highly experienced professional in the fields of biotech and venture capital, currently serving as a Senior Analyst at PitchBook Data and Morningstar, focusing on VC/PE trends in biotechnology and healthcare. Kazi also acts as a Venture Investment Advisor at KYH Ventures, providing strategic guidance to startups and investors. Previous roles include positions at HBM Partners AG and ARCH Venture Partners, as well as research fellowships and work in chemical and biomedical engineering. Kazi holds a Ph.D. from Northwestern University and an MBA from the Quantic School of Business and Technology, alongside a Bachelor's degree from New York University.